Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD (2021 Conference) (LDN, low dose naltrexone)

 

Eosinophilic Esophagitis Is More Treatable Than You Think - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

 

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

 

Mold toxicity - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

 

Atopic Dermatitis - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Atopic dermatitis is a hereditary skin disorder, and the most common form of eczema. Dr. Smith reviews the pathophysiology and diagnostic criteria for atopic dermatitis, as well as some causes.

 

Brian Udell, MD - Review of Recent Statistics for Patients Taking LDN in a Special Needs Pediatric Practice (2017 Conference) (LDN, low dose naltrexone)

 

Darin Ingels, ND - LDN and Children (2017 Conference) (LDN, low dose naltrexone)

Research on LDN in children shows it is safe with low side effects. Studies where LDN was used successfully in children: 2 with Crohn’s, 2 with autism, 1 with CRPS. His cases: autism; Hashimoto’s; IBS.

 

Dr. Brian Udell, Low Dose Naltrexone - Key Ingredient in the biomedical treatment of Autism Spectrum Disorder.

Learn about autism, the epidemic, and how LDN fits into a comprehensive therapeutic protocol to allow healing to take place. 

 

LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

 

Paul Battle, PA-C - Autoimmune Hepatitis (2019 Conference) (LDN, low dose naltrexone)